Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.28
OMI's Cash to Debt is ranked lower than
76% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.71 vs. OMI: 0.28 )
Ranked among companies with meaningful Cash to Debt only.
OMI' s 10-Year Cash to Debt Range
Min: 0  Med: 0.05 Max: 1.06
Current: 0.28
0
1.06
Equity to Asset 0.36
OMI's Equity to Asset is ranked lower than
63% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.45 vs. OMI: 0.36 )
Ranked among companies with meaningful Equity to Asset only.
OMI' s 10-Year Equity to Asset Range
Min: 0.2  Med: 0.38 Max: 0.49
Current: 0.36
0.2
0.49
F-Score: 7
Z-Score: 5.19
M-Score: -2.32
WACC vs ROIC
10.28%
6.12%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.61
OMI's Operating margin (%) is ranked lower than
67% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.95 vs. OMI: 1.61 )
Ranked among companies with meaningful Operating margin (%) only.
OMI' s 10-Year Operating margin (%) Range
Min: 0.89  Med: 2.33 Max: 2.57
Current: 1.61
0.89
2.57
Net-margin (%) 0.63
OMI's Net-margin (%) is ranked lower than
72% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.84 vs. OMI: 0.63 )
Ranked among companies with meaningful Net-margin (%) only.
OMI' s 10-Year Net-margin (%) Range
Min: -0.38  Med: 1.13 Max: 1.36
Current: 0.63
-0.38
1.36
ROE (%) 5.96
OMI's ROE (%) is ranked lower than
67% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.47 vs. OMI: 5.96 )
Ranked among companies with meaningful ROE (%) only.
OMI' s 10-Year ROE (%) Range
Min: 5.44  Med: 12.98 Max: 18.62
Current: 5.96
5.44
18.62
ROA (%) 2.29
OMI's ROA (%) is ranked lower than
67% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.18 vs. OMI: 2.29 )
Ranked among companies with meaningful ROA (%) only.
OMI' s 10-Year ROA (%) Range
Min: 1.69  Med: 4.81 Max: 6.2
Current: 2.29
1.69
6.2
ROC (Joel Greenblatt) (%) 17.59
OMI's ROC (Joel Greenblatt) (%) is ranked lower than
60% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.54 vs. OMI: 17.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 17.08  Med: 25.16 Max: 38.01
Current: 17.59
17.08
38.01
Revenue Growth (3Y)(%) 3.40
OMI's Revenue Growth (3Y)(%) is ranked lower than
69% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.80 vs. OMI: 3.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMI' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.6  Med: 4.20 Max: 13.5
Current: 3.4
-0.6
13.5
EBITDA Growth (3Y)(%) -1.80
OMI's EBITDA Growth (3Y)(%) is ranked lower than
71% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. OMI: -1.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OMI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -1.8  Med: 6.40 Max: 37.2
Current: -1.8
-1.8
37.2
EPS Growth (3Y)(%) -16.60
OMI's EPS Growth (3Y)(%) is ranked lower than
83% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. OMI: -16.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMI' s 10-Year EPS Growth (3Y)(%) Range
Min: -16.6  Med: 14.20 Max: 50.9
Current: -16.6
-16.6
50.9
» OMI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

OMI Guru Trades in Q2 2014

John Hussman 5,000 sh (New)
Chuck Royce 2,305,944 sh (+11.81%)
Mario Gabelli 208,229 sh (unchged)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Joel Greenblatt Sold Out
Pioneer Investments 584,600 sh (-0.50%)
David Dreman 256,603 sh (-2.04%)
Paul Tudor Jones 30,637 sh (-21.11%)
John Keeley 25,045 sh (-24.67%)
Jim Simons 337,150 sh (-30.87%)
» More
Q3 2014

OMI Guru Trades in Q3 2014

Richard Pzena 525,138 sh (New)
Jeremy Grantham 9,211 sh (New)
John Keeley 37,215 sh (+48.59%)
Chuck Royce 2,450,044 sh (+6.25%)
David Dreman 260,057 sh (+1.35%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
John Hussman 5,000 sh (unchged)
Pioneer Investments 589,916 sh (unchged)
Mario Gabelli 208,229 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones 22,600 sh (-26.23%)
» More
Q4 2014

OMI Guru Trades in Q4 2014

Joel Greenblatt 14,592 sh (New)
Jim Simons 95,750 sh (New)
Richard Pzena 893,816 sh (+70.21%)
Paul Tudor Jones 23,774 sh (+5.19%)
David Dreman 272,412 sh (+4.75%)
Pioneer Investments 593,231 sh (+0.56%)
Mario Gabelli 208,229 sh (unchged)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Jeremy Grantham Sold Out
John Hussman Sold Out
John Keeley 35,915 sh (-3.49%)
Chuck Royce 1,683,050 sh (-31.31%)
» More
Q1 2015

OMI Guru Trades in Q1 2015

James Barrow 115,387 sh (New)
Jim Simons 163,450 sh (+70.70%)
Richard Pzena 1,077,426 sh (+20.54%)
Paul Tudor Jones 27,000 sh (+13.57%)
Pioneer Investments 596,631 sh (+0.57%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli 203,650 sh (-2.20%)
John Keeley 35,015 sh (-2.51%)
Chuck Royce 1,594,250 sh (-5.28%)
David Dreman 234,729 sh (-13.83%)
» More
» Details

Insider Trades

Latest Guru Trades with OMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.85
OMI's P/E(ttm) is ranked lower than
71% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 25.20 vs. OMI: 34.85 )
Ranked among companies with meaningful P/E(ttm) only.
OMI' s 10-Year P/E(ttm) Range
Min: 13.55  Med: 19.20 Max: 36.14
Current: 34.85
13.55
36.14
Forward P/E 15.80
OMI's Forward P/E is ranked higher than
60% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.54 vs. OMI: 15.80 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 36.30
OMI's PE(NRI) is ranked lower than
74% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 25.20 vs. OMI: 36.30 )
Ranked among companies with meaningful PE(NRI) only.
OMI' s 10-Year PE(NRI) Range
Min: 13.47  Med: 18.82 Max: 36.25
Current: 36.3
13.47
36.25
P/B 2.14
OMI's P/B is ranked higher than
55% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.68 vs. OMI: 2.14 )
Ranked among companies with meaningful P/B only.
OMI' s 10-Year P/B Range
Min: 1.79  Med: 2.27 Max: 3.1
Current: 2.14
1.79
3.1
P/S 0.22
OMI's P/S is ranked higher than
88% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.11 vs. OMI: 0.22 )
Ranked among companies with meaningful P/S only.
OMI' s 10-Year P/S Range
Min: 0.18  Med: 0.23 Max: 0.29
Current: 0.22
0.18
0.29
PFCF 553.83
OMI's PFCF is ranked lower than
100% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.94 vs. OMI: 553.83 )
Ranked among companies with meaningful PFCF only.
OMI' s 10-Year PFCF Range
Min: 5.38  Med: 17.69 Max: 2216.7
Current: 553.83
5.38
2216.7
POCF 29.13
OMI's POCF is ranked lower than
74% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.49 vs. OMI: 29.13 )
Ranked among companies with meaningful POCF only.
OMI' s 10-Year POCF Range
Min: 4.92  Med: 14.25 Max: 63.05
Current: 29.13
4.92
63.05
EV-to-EBIT 16.79
OMI's EV-to-EBIT is ranked higher than
55% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.91 vs. OMI: 16.79 )
Ranked among companies with meaningful EV-to-EBIT only.
OMI' s 10-Year EV-to-EBIT Range
Min: 8  Med: 11.10 Max: 20.3
Current: 16.79
8
20.3
PEG 60.50
OMI's PEG is ranked lower than
100% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.44 vs. OMI: 60.50 )
Ranked among companies with meaningful PEG only.
OMI' s 10-Year PEG Range
Min: 0.87  Med: 2.75 Max: 207.15
Current: 60.5
0.87
207.15
Shiller P/E 19.33
OMI's Shiller P/E is ranked higher than
84% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 32.31 vs. OMI: 19.33 )
Ranked among companies with meaningful Shiller P/E only.
OMI' s 10-Year Shiller P/E Range
Min: 16.31  Med: 21.78 Max: 29.65
Current: 19.33
16.31
29.65
Current Ratio 1.81
OMI's Current Ratio is ranked higher than
61% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. OMI: 1.81 )
Ranked among companies with meaningful Current Ratio only.
OMI' s 10-Year Current Ratio Range
Min: 1.55  Med: 1.85 Max: 2.45
Current: 1.81
1.55
2.45
Quick Ratio 0.96
OMI's Quick Ratio is ranked lower than
68% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.26 vs. OMI: 0.96 )
Ranked among companies with meaningful Quick Ratio only.
OMI' s 10-Year Quick Ratio Range
Min: 0.6  Med: 0.93 Max: 1.21
Current: 0.96
0.6
1.21
Days Inventory 36.29
OMI's Days Inventory is ranked higher than
60% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.85 vs. OMI: 36.29 )
Ranked among companies with meaningful Days Inventory only.
OMI' s 10-Year Days Inventory Range
Min: 34.59  Med: 36.98 Max: 40.9
Current: 36.29
34.59
40.9
Days Sales Outstanding 22.77
OMI's Days Sales Outstanding is ranked higher than
85% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.91 vs. OMI: 22.77 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMI' s 10-Year Days Sales Outstanding Range
Min: 17.8  Med: 25.27 Max: 35.56
Current: 22.77
17.8
35.56

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.02
OMI's Dividend Yield is ranked higher than
78% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. OMI: 3.02 )
Ranked among companies with meaningful Dividend Yield only.
OMI' s 10-Year Dividend Yield Range
Min: 1.47  Med: 2.18 Max: 3.19
Current: 3.02
1.47
3.19
Dividend Payout 1.05
OMI's Dividend Payout is ranked lower than
93% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.36 vs. OMI: 1.05 )
Ranked among companies with meaningful Dividend Payout only.
OMI' s 10-Year Dividend Payout Range
Min: 0.21  Med: 0.34 Max: 4.29
Current: 1.05
0.21
4.29
Dividend growth (3y) 7.70
OMI's Dividend growth (3y) is ranked lower than
84% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.90 vs. OMI: 7.70 )
Ranked among companies with meaningful Dividend growth (3y) only.
OMI' s 10-Year Dividend growth (3y) Range
Min: 3.5  Med: 12.80 Max: 19.7
Current: 7.7
3.5
19.7
Yield on cost (5-Year) 4.95
OMI's Yield on cost (5-Year) is ranked higher than
89% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.67 vs. OMI: 4.95 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
OMI' s 10-Year Yield on cost (5-Year) Range
Min: 2.41  Med: 3.58 Max: 5.23
Current: 4.95
2.41
5.23
Share Buyback Rate 0.40
OMI's Share Buyback Rate is ranked higher than
62% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.10 vs. OMI: 0.40 )
Ranked among companies with meaningful Share Buyback Rate only.
OMI' s 10-Year Share Buyback Rate Range
Min: 0.4  Med: -1.30 Max: -5.3
Current: 0.4

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 15.75
OMI's Price/Net Current Asset Value is ranked lower than
85% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.68 vs. OMI: 15.75 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
OMI' s 10-Year Price/Net Current Asset Value Range
Min: 3.55  Med: 5.84 Max: 106.43
Current: 15.75
3.55
106.43
Price/Tangible Book 4.69
OMI's Price/Tangible Book is ranked lower than
63% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.81 vs. OMI: 4.69 )
Ranked among companies with meaningful Price/Tangible Book only.
OMI' s 10-Year Price/Tangible Book Range
Min: 2.72  Med: 4.43 Max: 175
Current: 4.69
2.72
175
Price/Projected FCF 1.28
OMI's Price/Projected FCF is ranked higher than
62% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. OMI: 1.28 )
Ranked among companies with meaningful Price/Projected FCF only.
OMI' s 10-Year Price/Projected FCF Range
Min: 0.84  Med: 1.40 Max: 2.72
Current: 1.28
0.84
2.72
Price/Median PS Value 0.94
OMI's Price/Median PS Value is ranked higher than
74% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.28 vs. OMI: 0.94 )
Ranked among companies with meaningful Price/Median PS Value only.
OMI' s 10-Year Price/Median PS Value Range
Min: 0.37  Med: 0.94 Max: 1.21
Current: 0.94
0.37
1.21
Price/Graham Number 2.70
OMI's Price/Graham Number is ranked lower than
63% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.82 vs. OMI: 2.70 )
Ranked among companies with meaningful Price/Graham Number only.
OMI' s 10-Year Price/Graham Number Range
Min: 1.36  Med: 1.93 Max: 14.38
Current: 2.7
1.36
14.38
Earnings Yield (Greenblatt) (%) 6.19
OMI's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.70 vs. OMI: 6.19 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMI' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 4.9  Med: 9.00 Max: 12.4
Current: 6.19
4.9
12.4
Forward Rate of Return (Yacktman) (%) 2.76
OMI's Forward Rate of Return (Yacktman) (%) is ranked lower than
73% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.36 vs. OMI: 2.76 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OMI' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 2.5  Med: 10.00 Max: 20.9
Current: 2.76
2.5
20.9

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Traded in other countries:6OM.Germany,
Owens & Minor, Inc., was founded in 1882 and incorporated in 1926 in Richmond, Virginia. The Company is a healthcare logistics company that connects the world of medical products to the point of care. It provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Company on August 31, 2012, acquired the Movianto Group (Movianto), an established European healthcare third-party logistics provider. The Company's domestic segment includes all functions in the United States relating to Company's role as a healthcare services company providing distribution and logistics services to healthcare providers and manufacturers. The International segment consists of Movianto, Company's European third-party logistics service. The Company's competitors are Cardinal Health, Inc. and privately-held Medline, Inc. The Domestic segment had 43 distribution centers as well as office and warehouse space across the United States. The International segment leases18 and owns two logistics centers across 11 European countries. The Company provides distribution, outsourced resource management and/or consulting services to thousands of healthcare provider customers which include multi-facility networks of healthcare providers offering a broad spectrum of healthcare services to a particular market or markets (IHNs) as well as smaller, independent hospitals in the United States. The medical/surgical supply distribution industry is subject to regulation by federal, state and local government agencies.
» More Articles for OMI

Headlines

Articles On GuruFocus.com
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Guru-Held Stocks Near Historical Low P/S Oct 03 2014 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Trading Near Historical Low P/S Ratios Jul 18 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Jun 04 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 20 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 

More From Other Websites
Dynatronics Announces Completion of $4,025,000 Private Placement Led by Prettybrook Partners Jul 01 2015
Coverage initiated on Owens & Minor by RBC Capital Mkts Jun 10 2015
OWENS & MINOR INC/VA/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial... May 22 2015
Owens & Minor Names P. Cody Phipps President & Chief Executive Officer, Effective July 1 May 20 2015
Owens & Minor Names P. Cody Phipps President & Chief Executive Officer, Effective July 1 May 20 2015
Owens & Minor Renews Lease in Duke Realty’s Lakeside Ranch Building 20 May 20 2015
OWENS & MINOR INC/VA/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... May 05 2015
10-Q for Owens & Minor, Inc. Apr 30 2015
NYSE stocks posting largest volume increases Apr 29 2015
Owens & Minor Announces Second Quarter 2015 Cash Dividend of $0.2525 per Share Apr 29 2015
Owens & Minor Announces Second Quarter 2015 Cash Dividend of $0.2525 per Share Apr 29 2015
Owens & Minor Inc Earnings Call scheduled for 8:30 am ET today Apr 28 2015
OWENS & MINOR INC/VA/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 28 2015
Owens & Minor meets 1Q profit forecasts Apr 27 2015
Owens & Minor meets 1Q profit forecasts Apr 27 2015
Owens & Minor Reports 1st Quarter 2015 Financial Results Apr 27 2015
Q1 2015 Owens & Minor Inc Earnings Release - After Market Close Apr 27 2015
Owens & Minor Plans to Release First-Quarter 2015 Financial Results on Monday, April 27th;... Apr 10 2015
Owens & Minor Reports 4th Quarter & Full-Year 2014 Financial Results Mar 07 2015
OWENS & MINOR INC/VA/ Financials Feb 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK